A5075701065- Peripheral Artery Disease Management
- Vascular Procedures and Complications
- Venous Thromboembolism Diagnosis and Management
- Diagnosis and Treatment of Venous Diseases
- Central Venous Catheters and Hemodialysis
- Cerebrovascular and Carotid Artery Diseases
- Coronary Interventions and Diagnostics
- Aortic aneurysm repair treatments
- Cardiac Imaging and Diagnostics
- Acute Ischemic Stroke Management
- Acute Myocardial Infarction Research
- Diabetic Foot Ulcer Assessment and Management
- Cardiac Valve Diseases and Treatments
- Muscle and Compartmental Disorders
- Orthopaedic implants and arthroplasty
- Atrial Fibrillation Management and Outcomes
- Cardiac, Anesthesia and Surgical Outcomes
- Pelvic and Acetabular Injuries
- Heart Failure Treatment and Management
- COVID-19 and healthcare impacts
- Corporate Governance and Management
- Aortic Disease and Treatment Approaches
- Vascular anomalies and interventions
- Anatomy and Medical Technology
- Delphi Technique in Research
Klinikum Arnsberg
2016-2025
Medical University of Graz
2024
Deutsche Gesellschaft für Gefäßchirurgie und Gefäßmedizin
2020
University Hospital Bonn
2020
Martin Luther University Halle-Wittenberg
2020
University Hospital Heidelberg
2020
Center for Clinical Studies
2020
University Hospital Leipzig
2020
Jena University Hospital
2020
Heidelberg University
2020
The authors sought to evaluate the performance of Ranger paclitaxel-coated balloon versus uncoated angioplasty for femoropopliteal lesions at 12 months. Drug-coated balloons (DCBs) are a promising endovascular treatment option peripheral artery disease segment, and each unique device requires dedicated clinical study. prospective, randomized RANGER SFA (Comparison Ranger™ Paclitaxel-Coated PTA Balloon Catheter Uncoated Balloons in Femoropopliteal Arteries) study (NCT02013193) enrolled 105...
Abstract Purpose To assess safety and patency of the Venovo venous stent for treatment iliofemoral vein obstruction. Materials Methods Twenty-two international centers enrolled 170 patients in VERNACULAR study (93 post-thrombotic syndrome; 77 non-thrombotic iliac lesions). Primary outcome measures were major adverse events at 30 days 12-month primary (freedom from target vessel revascularization, thrombotic occlusion, or stenosis > 50%). Secondary outcomes included Venous Clinical...
Purpose To report 36-month outcomes and subgroup analysis of the ABRE Study evaluating safety effectiveness Abre venous self-expanding stent system for treatment symptomatic iliofemoral outflow obstruction disease. Methods The was a prospective, multicenter, non-randomized study that enrolled implanted stents in 200 participants (mean age 51.5±15.9 years 66.5% women) with at 24 global sites. Outcomes assessed through 36 months included patency, major adverse events, migration, fracture,...
Background: This study aimed to assess the peri- and postprocedural outcomes of atherectomy-assisted endovascular treatment common femoral (CFA) popliteal arteries. Methods: Phoenix atherectomy was used for 73 53 de novo CFA artery lesions, respectively, in 122 consecutive patients. Safety endpoints encompassed perforation peripheral embolization. Postprocedural included freedom from clinically driven target lesion revascularization (CD-TLR) clinical success (an improvement ⩾ 2 Rutherford...
Background: In patients with post-thrombotic syndrome (PTS), stent recanalization of iliofemoral veins or the inferior vena cava can restore venous patency and improve functional outcomes. The risk thrombosis is particularly increased during first 6 months after intervention. ARIVA trial tested whether daily aspirin 100 mg plus rivaroxaban 20 superior to alone prevent within placement for PTS. Methods: this multinational, academic, open-label, independently adjudicated trial, a Villalta...
Purpose: To evaluate the performance of Ranger paclitaxel-coated balloon vs uncoated angioplasty for femoropopliteal lesions. Methods: Between January 2014 and October 2015, prospective, randomized RANGER SFA study ( ClinicalTrials.gov identifier NCT02013193) enrolled 105 patients with symptomatic lower limb ischemia (Rutherford category 2–4) stenotic lesions in nonstented segment at 10 European centers. Seventy-one (mean age 68±8 years; 53 men) were drug-coated (DCB) arm 34 67±9 23 assigned...
Purpose: To describe a preliminary experience in treating no-option critical limb ischemia (CLI) patients with hybrid foot vein arterialization (HFVA) technique combining open plus endovascular approaches. Materials and Methods: Between May 2016 January 2018, 35 consecutive (mean age 68±12 years; 28 men) 36 CLI limbs underwent HFVA our center. All had grade 3 WIfI (Wound, Ischemia, Infection) ischemia, the wound classification was 1 4 (11%) limbs, 2 (11%), (78%). Surgical bypass done on...
Endovascular atherectomy enables minimally invasive plaque removal in peripheral artery disease (PAD).We aimed to evaluate the safety and long-term effectiveness of Phoenix for treatment complex calcified lesions PAD patients.Consecutive all-comer patients with underwent atherectomy. Device terms perforation distal embolisation were evaluated. Lesion calcifications categorised by Peripheral Arterial Calcium Scoring System (PACSS) lesion complexity was assessed Transatlantic Inter-Society...
With an increasing global burden of patients with chronic peripheral artery disease (PAD) the safe and effective provision lower limb revascularisation is a growing medical need. Endovascular procedures for treatment PAD have become crucial cornerstone modern vascular medicine, first line approach if technically feasible taking patient choice into consideration. age number comorbidities open surgery also often not feasible. We outline framework key messages, endorsed by board European...
Objective There is a need for improved outcomes in the endovascular treatment of patients suffering from chronic limb threatening ischaemia (CLTI), highly calcified lesions and total occlusions (CTOs). The helical centreline self expanding BioMimics 3D stent might be particularly useful these high risk subsets, combining flexibility fracture resistance with radial strength. Herein, performance was assessed subsets. Methods MIMICS-3D prospective, multicentre European real world registry. This...
: We aimed to study the long-term safety and efficacy of oblique venous stents for post-thrombotic syndrome (PTS) with iliac vein compression.
We investigated the safety and efficacy of debulking infrainguinal lesions in patients with peripheral artery disease (PAD) undergoing endovascular revascularization (EVR) as part RECording Courses vascular Diseases (RECCORD) registry. Patient lesion specific characteristics, including complexity score (LCS) were analyzed. The primary endpoint encompassed: (i) clinical improvement Rutherford categories, (ii) index limb re-interventions, (iii) major amputations during follow-up. secondary...
Summary: Background: This prospective, single center, exploratory study assessed primary patency, clinical performance, and adverse events associated with the DUO-HYBRID Venous Stent used to treat iliac vein obstruction. Materials methods: Twenty-one patients symptomatic obstructions were treated self-expanding stent designed varying zones of fatigue crush resistance adapt challenging anatomy. The outcome measure was 12-month defined as ≤ 50% residual stenosis, absence re-thrombosis or...